About China focus @ JPM WEEK

Since the recent reform of China’s drug approval process, clinical trials and new drug approval in China has speeded up. In 2017 alone, 34 pharma products and 5 biotech products were approved, making a record high in the history. It opened door for drug development companies around the world to the Chinese market and also ignited license-in interest from Chinese public pharma companies.

China [email protected] week is bringing together investors and pharma leaders from China and healthcare innovators for an exclusive event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations from around the world. The forum features premier 1-to-1 networking opportunities prior and during the forum.